BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1748914)

  • 1. Nursing perspectives on intraperitoneal chemotherapy.
    Hoff ST
    J Intraven Nurs; 1991; 14(5):309-14. PubMed ID: 1748914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal antineoplastic agents in the management of ovarian cancer.
    Tropé C; Kaern J; Vergote I
    Eur J Surg Suppl; 1991 May; (561):83-6. PubMed ID: 1720054
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraperitoneal therapy in the management of patients with ovarian cancer.
    McClay EF; Howell SB
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):915-26. PubMed ID: 1500393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal chemotherapy for ovarian carcinoma.
    Markman M
    Biomed Pharmacother; 1987; 41(8):420-4. PubMed ID: 3330457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Theoretical and experimental bases for intraperitoneal chemotherapy in abdominal neoplastic processes].
    Marinov L
    Khirurgiia (Sofiia); 1986; 39(4):11-7. PubMed ID: 3784379
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraperitoneal chemotherapy: implications beyond ovarian cancer.
    Marin K; Oleszewski K; Muehlbauer P
    Clin J Oncol Nurs; 2007 Dec; 11(6):881-9. PubMed ID: 18063547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use and nursing of intraperitoneal chemotherapy for ovarian cancer].
    Gao SY; Han JH; Li HY
    Zhonghua Hu Li Za Zhi; 1996 Apr; 31(4):211-2. PubMed ID: 8826214
    [No Abstract]   [Full Text] [Related]  

  • 8. Implementation of intraperitoneal chemotherapy for the treatment of ovarian cancer.
    Hydzik C
    Clin J Oncol Nurs; 2007 Apr; 11(2):221-5. PubMed ID: 17573271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The port: delivering intraperitoneal chemotherapy in ovarian cancer.
    Doane LS
    Todays OR Nurse; 1992 Sep; 14(9):11-8. PubMed ID: 1412628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nursing management of intraperitoneal therapy.
    Swenson KK; Erikson JH
    Oncol Nurs Forum; 1986; 13(5):33-9. PubMed ID: 3638717
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Petru E; Benedicic Ch; Huell A
    Gynecol Oncol; 2006 Jul; 102(1):129; author reply 130. PubMed ID: 16600354
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges of IP chemotherapy for ovarian cancer.
    Anselmo-Murphy AM
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):21-2. PubMed ID: 19856604
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations.
    Potter KL; Held-Warmkessel J
    Clin J Oncol Nurs; 2008 Apr; 12(2):265-71. PubMed ID: 18390462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concepts in intraperitoneal chemotherapy.
    Hoff ST
    Semin Oncol Nurs; 1987 May; 3(2):112-7. PubMed ID: 3646722
    [No Abstract]   [Full Text] [Related]  

  • 15. Problems associated with the administration of intraperitoneal therapy using the Port-A-Cath system.
    Almadrones L; Yerys C
    Oncol Nurs Forum; 1990; 17(1):75-80. PubMed ID: 2300507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal chemotherapy.
    Markman M
    Semin Oncol; 1991 Jun; 18(3):248-54. PubMed ID: 2042064
    [No Abstract]   [Full Text] [Related]  

  • 17. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
    In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intraperitoneal chemotherapy in ovarian carcinoma].
    Piura B
    Harefuah; 2001 Sep; 140(9):844-9, 894, 893. PubMed ID: 11579736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment.
    Muggia FM
    Semin Oncol; 2006 Dec; 33(6 Suppl 12):S18-24. PubMed ID: 17223446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications associated with intraperitoneal chemotherapy catheters.
    Makhija S; Leitao M; Sabbatini P; Bellin N; Almadrones L; Leon L; Spriggs DR; Barakat R
    Gynecol Oncol; 2001 Apr; 81(1):77-81. PubMed ID: 11277654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.